Differential involvement of -opioid receptor subtypes in endomorphin-1- and -2-induced antinociception

By Sakurada S.   Zadina J.E.   Kastin A.J.   Katsuyama S.   Fujimura T.   Murayama K.   Yuki M.   Ueda H.   Sakurada T.  

European Journal of Pharmacology, Vol. 372, Iss. 1, 1999-05 ,pp. : 25-30

Elsevier

Access to resources Recommend Favorite

The antitussive effects of endomorphin-1 and endomorphin-2 in mice

By Kamei J.   Morita K.   Saitoh A.   Nagase H.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 219-222

Elsevier

Access to resources Recommend Favorite

Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 2, 2016-01 ,pp. : 141-155

Bentham Science Publishers

Access to resources Recommend Favorite

The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice

By Kamei J.   Zushida K.   Ohsawa M.   Nagase H.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 91-96

Elsevier

Access to resources Recommend Favorite

Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy

By Al-Khrasani M.   Orosz G.   Kocsis L.   Farkas V.   Magyar A.   Lengyel I.   Benyhe S.   Borsodi A.   Ronai A.Z.  

European Journal of Pharmacology, Vol. 421, Iss. 1, 2001-06 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite